labetalol has been researched along with arginine vasopressin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brown, M; Hauger, R; Mirow, A; Partridge, BL; Weinger, MB | 1 |
Burrin, JM; Hall, GM; Loughnan, BA; Matson, AM; Shaw, M | 1 |
1 review(s) available for labetalol and arginine vasopressin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for labetalol and arginine vasopressin
Article | Year |
---|---|
Prevention of the cardiovascular and neuroendocrine response to electroconvulsive therapy: II. Effects of pretreatment regimens on catecholamines, ACTH, vasopressin, and cortisol.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Arginine Vasopressin; Catecholamines; Electroconvulsive Therapy; Hemodynamics; Humans; Hydrocortisone; Labetalol; Middle Aged; Propanolamines | 1991 |
Pituitary-adrenal, hormonal changes during induced hypotension with labetol or isoflurane for middle-ear surgery.
Topics: Adrenal Cortex Hormones; Adrenergic Antagonists; Adrenergic beta-Antagonists; Adrenocorticotropic Hormone; Adult; Aldosterone; Analysis of Variance; Anesthetics, Inhalation; Antihypertensive Agents; Arginine Vasopressin; Blood Pressure; Ear, Middle; Follow-Up Studies; Humans; Hydrocortisone; Hypotension, Controlled; Injections, Intravenous; Isoflurane; Labetalol; Metoprolol; Oxygen; Pituitary Hormones; Pituitary-Adrenal System; Sample Size | 1998 |
1 other study(ies) available for labetalol and arginine vasopressin
Article | Year |
---|---|
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |